ZSAN - Zosano Pharma C Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 XLF (0%) F (0%) AAPL (0%) APPS (0%) BTCUSD (%) FUTU (0%) NDAQ (0%) REGI (0%) SPWR (0%) XSPA (0%) EVGN (0%) ETSY (0%) ETHUSD (%) ENDP (0%) ELY (0%) DQ (0%) DGLY (0%) DFS (0%) DAR (0%) DAL (0%) CVET (0%) CRSP (0%) COWN (0%) CELH (0%) BIOL (0%)

Recommendation

Service : FEAT. ANDRE 3000 | Trader : JOHN KROLIKOWSKI JR | Trade Date : 11/13/20

$ZSAN - Zosano Pharma Corporation

Buy Long

Trade

122.22 %

Target

$0.45

Issue Price

$1.00

Target Price

11/13/21

Target Date

$0.24

Stop Loss

Trade Closed - WINNER

Hit Target Price

Reason

96.45 %

P/L %

$0.88

Close Price

53

Days Held

01/05/21

Closed Date

To view trade details and get more recommendations from this trader Subscribe

ZSAN - Zosano Pharma Corpor...

$1.08 0.02[1.89%]

15 mins delayed data

People also watch :

+Watchlist

6 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$1.08	Open
Volume	276.1K	Market Cap	72.7M
Yield		Last Dividend

Day

52 Week

Zosano Pharma (ZSAN) in Focus: Stock Mov...	01/12/21
Zosano Pharma (ZSAN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Zosano Pharma Requests Type A Meeting wi...	01/04/21
FREMONT, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announce...

Zosano Pharma to Present at the H.C. Wai...	01/04/21
FREMONT, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announce...

DEADLINE TODAY: The Schall Law Firm Anno...	12/28/20
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Zosano Pharma Corporation.

Zhang Investor Law Reminds Investors of ...	12/27/20
NEW YORK, Dec. 27, 2020 (GLOBE NEWSWIRE) ??? Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Zosano...

ZSAN Deadline: Bronstein, Gewirtz & Gros...	12/27/20
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zosano Pharma Corporation (

ZSAN FINAL DEADLINE MONDAY: ROSEN, A LEA...	12/24/20
NEW YORK, Dec. 24, 2020 /PRNewswire/ ??? Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corp...

LOOMING ZSAN DEADLINE: Pawar Law Group A...	12/08/20
NEW YORK, Dec. 08, 2020 (GLOBE NEWSWIRE) ??? Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purcha...

DEADLINE ALERT for BMWYY, ZSAN, and WFC:...	12/07/20
LOS ANGELES, Dec. 07, 2020 (GLOBE NEWSWIRE) ??? The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behal...

ROSEN, RESPECTED INVESTOR COUNSEL, Remin...	12/04/20
NEW YORK, Dec. 04, 2020 (GLOBE NEWSWIRE) ??? Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma ...

SHAREHOLDER ALERT: Pomerantz Law Firm Re...	12/03/20
NEW YORK, Dec. 3, 2020 /PRNewswire/ ??? Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation (???Zosan...

The Gross Law Firm Announces Class Actio...	12/02/20
NEW YORK, NY / ACCESSWIRE / December 2, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of share...

ROSEN, TOP RANKED INVESTOR COUNSEL, Remi...	11/28/20
NEW YORK, Nov. 28, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corpo...

Microneedle Drug Delivery Systems Market...	11/27/20
DBMR has added a new report titled Microneedle Drug Delivery Systems Market with data Tables for historical and forecast years represented with Chats ...

Bragar Eagel & Squire, P.C. Reminds Trad...	11/24/20
Bragar Eagel & Squire, P.C. Reminds Traders That Class Motion Lawsuits Have Been Filed In opposition to JPMorgan, First American Monetary, BMW, and Zo...

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Rem...	11/18/20
NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) ??? Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma ...

SHAREHOLDER DEADLINE: Pawar Law Group An...	11/16/20
NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) ??? Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purcha...

The Law Offices of Frank R. Cruz Reminds...	11/12/20
LOS ANGELES, Nov. 12, 2020 /PRNewswire/ -- The Law Offices of Frank R. Cruz reminds investors of the upcoming December 28, 2020 deadline to file a lea...

ZSAN Shareholder Alert: Bronstein, Gewir...	11/11/20
NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zosano Pharma Corp...

ROSEN, A LEADING LAW FIRM, Reminds Zosan...	11/09/20
NEW YORK, Nov. 9, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corpor...

ROSEN, GLOBAL INVESTOR COUNSEL, Reminds ...	11/08/20
NEW YORK???(BUSINESS WIRE)???Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NAS...

Pomerantz Law Firm Announces the Filing ...	11/06/20
NEW YORK, Nov. 6, 2020 /PRNewswire/ ??? Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation (???Zosan...

The Daily Biotech Pulse: Bluebird Bio Pl...	11/05/20
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 4) Abbo...

Bragar Eagel & Squire, P.C. Reminds Inve...	11/04/20
NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) ??? Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that ...

Glancy Prongay & Murray LLP Reminds Inve...	11/04/20
LOS ANGELES--(BUSINESS WIRE)---- $ZSAN #CLASSACTION--Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Aga...

Attention Biotech Investors: Mark Your C...	11/03/20
The month of October could at best be termed as mixed from the perspective of drug approvals. Avenue Therapeutics Inc's (NASDAQ: ATXI ) pain drug and ...

ZSAN Shareholder Alert: Bronstein, Gewir...	11/03/20
NEW YORK, Nov. 3, 2020 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has b...

SHAREHOLDER ALERT: Law Offices of Timoth...	11/03/20
Investor Files Securities Class Action for Misleading Shareholders; Zosano Shareholders Are Urged to Contact the Law Offices of Timothy L. MIles

Shareholder Alert: Robbins LLP Announces...	11/02/20
SAN DIEGO & FREMONT, Calif.--(BUSINESS WIRE)---- $ZSAN #ClassAction--Shareholder rights law firm Robbins LLP announces that a purchaser of Zosano Phar...

ZOSANO ALERT: Bragar Eagel & Squire, P.C...	10/30/20
NEW YORK--(BUSINESS WIRE)-- #Zosano--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action l...

ANALYST RATINGS

2 analyst ratings (Last 3 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

Buy rating	11/25/20
HC Wainwright & Co. maintains Buy rating and lowers Price Target from $2.50 to $2.00

EARNINGS

Date	2020-11-13 (BMO)	Est. (EPS/Rev.)	($0.10)/ 0
Actual (EPS/Rev.)	$-0.11/	EPS (TTM)	0

TRADERS TRACKING $ZSAN

Service Name	Trader	% Success
FEAT. ANDRE 3000	JOHN KROLIKOWSKI JR	89.00 %	Subscribe
FEAT. PIMP C	JOHN KROLIKOWSKI JR	88.00 %	Follow
Big Data Zhou	Zhou Academy	82.00 %	Subscribe
Tech Trades	Tech Trades	81.00 %	Follow
ARCO TRADES	ARCO TRADES	64.00 %	Subscribe

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.